Cutler Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,600
Closed -$2K 5301
2022
Q2
$2K Buy
+3,600
New +$34.4K ﹤0.01% 4318
2021
Q4
Sell
-1,500
Closed -$2K 5833
2021
Q3
$2K Sell
1,500
-100
-6% -$4.63K ﹤0.01% 5051
2021
Q2
$3K Sell
1,600
-200
-11% -$8.86K ﹤0.01% 4795
2021
Q1
$10K Sell
1,800
-900
-33% -$46.9K ﹤0.01% 3813
2020
Q4
$29K Sell
2,700
-900
-25% -$40.7K ﹤0.01% 2391
2020
Q3
$12K Buy
3,600
+2,600
+260% +$96.7K ﹤0.01% 2862
2020
Q2
$1K Buy
+1,000
New +$27.7K ﹤0.01% 4100
2019
Q4
Sell
-27,800
Closed -$2K 4387
2019
Q3
$2K Buy
27,800
+14,700
+112% +$345K ﹤0.01% 3510
2019
Q2
$19K Buy
+13,100
New +$287K ﹤0.01% 2253
2017
Q1
Sell
-1,100
Closed -$1K 6922
2016
Q4
$1K Sell
1,100
-12,600
-92% -$108K ﹤0.01% 6072
2016
Q3
$22K Buy
13,700
+7,000
+104% +$58.7K ﹤0.01% 3331
2016
Q2
$19K Sell
6,700
-1,400
-17% -$11.2K ﹤0.01% 3424
2016
Q1
$1K Hold
8,100
﹤0.01% 6058
2015
Q4
$10K Buy
+8,100
New +$59.3K ﹤0.01% 4140

Other funds holding NEO

Cutler Group's NEO Position: Q3 2022 in Review

Cutler Group sold out of NeoGenomics (NEO) in Q3 2022, closing a stake of 2,478 shares — an estimated $20K sold.

Cutler Group first reported a position in NEO in Q2 2016 and held it in 12 quarters. The position peaked at $103K in Q1 2017. 245 funds tracked by Wall St. Rank hold NEO as of Q3 2022.

  • Cutler Group reported no remaining NeoGenomics position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 2,478 NeoGenomics shares in Q3 2022, an estimated $20K.
  • Cutler Group first reported a position in NeoGenomics in Q2 2016 and held it in 12 quarters.
  • Cutler Group's NeoGenomics position peaked at $103K in Q1 2017.
  • 245 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.